poor circulation in right hand; poor circulation in right foot; blurry vision - reduce vision; L arm is still slightly sore and painfui; doesn't recover the complete control of the arm; injection site arm pain; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (blurry vision - reduce vision), PAIN IN EXTREMITY (L arm is still slightly sore and painfui), LIMB DISCOMFORT (doesn't recover the complete control of the arm), INJECTION SITE PAIN (injection site arm pain) and SENSATION OF BLOOD FLOW (poor circulation in right hand) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included LATANOPROST for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced VISION BLURRED (blurry vision - reduce vision), PAIN IN EXTREMITY (L arm is still slightly sore and painfui), LIMB DISCOMFORT (doesn't recover the complete control of the arm) and INJECTION SITE PAIN (injection site arm pain). On 13-Mar-2021, the patient experienced SENSATION OF BLOOD FLOW (poor circulation in right hand) and SENSATION OF BLOOD FLOW (poor circulation in right foot). At the time of the report, VISION BLURRED (blurry vision - reduce vision), PAIN IN EXTREMITY (L arm is still slightly sore and painfui), LIMB DISCOMFORT (doesn't recover the complete control of the arm), INJECTION SITE PAIN (injection site arm pain), SENSATION OF BLOOD FLOW (poor circulation in right hand) and SENSATION OF BLOOD FLOW (poor circulation in right foot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Mar-2021: follow-up received on 16-Mar-2021 addition of three more events injection site arm pain, poor circulation in right hand and poor circulation in right foot. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Mar-2021 and was forwarded to Moderna on 05-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (blurry vision - reduce vision), PAIN IN EXTREMITY (L arm is still slightly sore and painfui), LIMB DISCOMFORT (doesn't recover the complete control of the arm), INJECTION SITE PAIN (injection site arm pain) and SENSATION OF BLOOD FLOW (poor circulation in right hand) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included LATANOPROST for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced VISION BLURRED (blurry vision - reduce vision), PAIN IN EXTREMITY (L arm is still slightly sore and painfui), LIMB DISCOMFORT (doesn't recover the complete control of the arm) and INJECTION SITE PAIN (injection site arm pain). On 13-Mar-2021, the patient experienced SENSATION OF BLOOD FLOW (poor circulation in right hand) and SENSATION OF BLOOD FLOW (poor circulation in right foot). At the time of the report, VISION BLURRED (blurry vision - reduce vision), PAIN IN EXTREMITY (L arm is still slightly sore and painfui), LIMB DISCOMFORT (doesn't recover the complete control of the arm), INJECTION SITE PAIN (injection site arm pain), SENSATION OF BLOOD FLOW (poor circulation in right hand) and SENSATION OF BLOOD FLOW (poor circulation in right foot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Mar-2021: follow-up received on 16-Mar-2021 addition of three more events injection site arm pain, poor circulation in right hand and poor circulation in right foot.